Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Other Accumulated Expenses (2018 - 2025)

Historic Other Accumulated Expenses for Mesa Laboratories (MLAB) over the last 8 years, with Q4 2025 value amounting to $2.4 million.

  • Mesa Laboratories' Other Accumulated Expenses rose 82.78% to $2.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.4 million, marking a year-over-year increase of 82.78%. This contributed to the annual value of $3.6 million for FY2025, which is 3370.37% up from last year.
  • As of Q4 2025, Mesa Laboratories' Other Accumulated Expenses stood at $2.4 million, which was up 82.78% from $2.5 million recorded in Q3 2025.
  • Mesa Laboratories' 5-year Other Accumulated Expenses high stood at $4.2 million for Q4 2023, and its period low was $703000.0 during Q3 2022.
  • For the 5-year period, Mesa Laboratories' Other Accumulated Expenses averaged around $2.4 million, with its median value being $2.4 million (2023).
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first skyrocketed by 57483.22% in 2021, then plummeted by 4827.83% in 2022.
  • Quarter analysis of 5 years shows Mesa Laboratories' Other Accumulated Expenses stood at $1.4 million in 2021, then plummeted by 48.28% to $721000.0 in 2022, then skyrocketed by 483.08% to $4.2 million in 2023, then tumbled by 42.53% to $2.4 million in 2024, then grew by 0.83% to $2.4 million in 2025.
  • Its Other Accumulated Expenses stands at $2.4 million for Q4 2025, versus $2.5 million for Q3 2025 and $3.9 million for Q2 2025.